ImageneBio, Inc.
Biotechnology company · San Diego, California, United States · Nasdaq: IMA
ImageneBio, Inc. is a biotechnology company headquartered in San Diego, California, United States. Its shares trade on Nasdaq under the ticker IMA. It has reported private securities offerings to the US SEC, most recently $43 million sold in a notice filed in 2023.
ImageneBio at a glance
What does ImageneBio do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $42.6 million sold (2023).
Frequently asked questions about ImageneBio
Where is ImageneBio headquartered?
ImageneBio, Inc. is headquartered in San Diego, California, United States.
What does ImageneBio do?
ImageneBio, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is ImageneBio a public company?
Yes. ImageneBio, Inc. trades on Nasdaq under the ticker IMA.
Similar companies
- Biolinq IncSan Diego, California, United States
- BioAtla, Inc.San Diego, California, United States
- Neurocrine Biosciences IncSan Diego, California, United States
- ImmunityBio, Inc.San Diego, California, United States
- Sorrento Therapeutics, Inc.San Diego, California, United States
- Protego Biopharma, Inc.San Diego, California, United States
- Tempo Therapeutics, Inc.San Diego, California, United States
- Fate Therapeutics IncSan Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.